How to Cite
Abstract
Editorial
References
Tillett WS, Francis T. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-71. http://dx.doi.org/10.1084/jem.52.4.561
Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999; 7: 169-77. http://dx.doi.org/10.1016/S0969-2126(99)80023-9
Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 2004; 148: S19-S26. http://dx.doi.org/10.1016/j.ahj.2004.04.028
Nguyen-Vermillion A, Juul SE, McPherson RJ, Ledbetter DJ. Time course of C-reactive protein and inflammatory mediators after neonatal surgery. J Pediatr 2011; 159: 121-6. http://dx.doi.org/10.1016/j.jpeds.2010.12.048
Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991; 23: 118-24. http://dx.doi.org/10.3109/00313029109060809
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-12.
Myers GL, Rifai N, Tracy RP, et al. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group. Circulation 2004; 110: e545-9.
Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 483-95. http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00009
Lewandrowski K, Chen A, Januzzi J. Cardiac markers for myocardial infarction. Am J Clin Pathol 2002; 118: S93-S99.
Pepys MB, Hirschfield GM, Tennent GA, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006; 440: 1217-21. http://dx.doi.org/10.1038/nature04672
Morimoto H, Sakata K, Oishi M, et al. Effect of high-sensitivity C-reactive protein on the development of diabetes as demonstrated by pooled logistic-regression analysis of annual health-screening information from male Japanese workers. Diabetes Metab 2012. http://dx.doi.org/10.1016/j.diabet.2012.03.004
Tomiyama H, Okazaki R, Koji Y, et al. Elevated C-reactive protein: a common marker for atherosclerotic cardiovascular risk and subclinical stages of pulmonary dysfunction and osteopenia in a healthy population. Atherosclerosis 2005; 178: 187-92. http://dx.doi.org/10.1016/j.atherosclerosis.2004.08.014
Kuo H-K, Yen C-J, Chen J-H, Yu Y-H, Bean JF. Association of cardiorespiratory fitness and levels of C-reactive protein: data from the National Health and Nutrition Examination Survey 1999-2002. Int J Cardiol 2007; 114: 28-33. http://dx.doi.org/10.1016/j.ijcard.2005.11.110
Groblewska M, Mroczko B, Sosnowska D, Szmitkowski M. Interleukin 6 and C-reactive protein in esophaeal cancer. Clin Chim Acta 2012. http://dx.doi.org/10.1016/j.cca.2012.05.009
Harris MT, Davis WW, Le N-A, et al. Free oxygen raicals in whole blood correlate strongly with high-sensitivity C-reactive protein. J Clin Pathol 2007; 1: 593-8.
Jansen LMA, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BAC. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001; 60: 924-7. http://dx.doi.org/10.1136/ard.60.10.924
Chundadze T, Steinvil A, Finn T, et al. Significantly elevated C-reactive protein serum levels are associated with very high 30-day mortality rates in hospitalized medical patients. Clin Biochem 2010; 43: 1060-3. http://dx.doi.org/10.1016/j.clinbiochem.2010.06.006
Kao PC, Shiesh S-C, Wu T-J. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 2006; 36: 163-9.
Wu S, Hsu L-A, Cheng C-F, et al. Effect of obesity on the association between ATF3 gene haplotypes and C-reactive protein level in Taiwanese. Clin Chim Acta 2011; 412: 1026-31. http://dx.doi.org/10.1016/j.cca.2011.02.011
Faucher G, Guenard F, Bouchard L, et al. Genetic contribution to C-reactive protein levels in severe obesity. Mol Genet Metab 2012; 105: 494-501. http://dx.doi.org/10.1016/j.ymgme.2011.11.198
Anan F, Masaki T, Kikuchi H, et al. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2010; 87: 233-9. http://dx.doi.org/10.1016/j.diabres.2009.10.017
Lin M-S, Shish S-R, Li H-Y, et al. Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men. Diab Res Clin Pract 2007; 77: 286-92. http://dx.doi.org/10.1016/j.diabres.2006.11.013
O'Bryant SE, Waring SC, Hobson V, et al. Decreased C-reactive protein levels in Alzheimer disease. J Geriatr Psychiatry Neurol 2010; 23: 49-53. http://dx.doi.org/10.1177/0891988709351832
Clos TWD. C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum 2003; 48: 1475-7. http://dx.doi.org/10.1002/art.11025
Testa R, Bonfigli AR, Sirolla C, et al. C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position – 675 of the PAI-1 gene. Nutr Metab Cardiovasc Dis 2008; 18: 220-6. http://dx.doi.org/10.1016/j.numecd.2006.10.001
Cetinkaya M, Ozkan H, Koksal N, Akaci O, Ozgur T. Comparison of the efficiency of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg 2011; 46: 1482-9. http://dx.doi.org/10.1016/j.jpedsurg.2011.03.069
Aronson D, Sheikh-Ahmad M, Avizohar O, et al. C-reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis 2004; 176: 173-9. http://dx.doi.org/10.1016/j.atherosclerosis.2004.04.025
Angulo JC, Gaspar MJ, Rodriguez N, Garcia-Tello A, Torres G, Nunez C. The value of C-reactive protein determination in patients with renal colic to decide to decide urgent urinary diversion. Urology 2010; 76: 301-6. http://dx.doi.org/10.1016/j.urology.2009.12.002
Dollner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001; 54: 1251-7. http://dx.doi.org/10.1016/S0895-4356(01)00400-0
Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med 1999; 17: 1019-25. http://dx.doi.org/10.1016/S0736-4679(99)00135-3
McDade TW, Burhop J, Dohnal J. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem 2004; 50: 652-4. http://dx.doi.org/10.1373/clinchem.2003.029488
Collet-Cassart D, Van den Abbeele E, Poncelet S. A quantitative C-reactive protein assay using latex agglutination in microtiter plates. J Immunol Meth 1989; 125: 137-41. http://dx.doi.org/10.1016/0022-1759(89)90086-0
Raj V, Sreenivasan K. Selective detection and estimation of C-reactive protein in serum using surface-functionalized gold nano-particles. Anal Chim Acta 2010; 662: 186-92. http://dx.doi.org/10.1016/j.aca.2010.01.007
Bryan T, Luo X, Bueno PR, Davis JJ. An optimised electrochemical biosensor for the label-free detection of C-reactive protein in blood. Biosens Bioelectron 2013; 39: 94-8. http://dx.doi.org/10.1016/j.bios.2012.06.051
Choi HW, Sakata Y, Kurihara Y, Ooya T, Takeuchi T. Label-free detection of C-reactive protein using reflectometric interference spectroscopy-based sensing system. Anal Chim Acta 2012 ; 728: 64-8. http://dx.doi.org/10.1016/j.aca.2012.03.030
Hu WP, Hsu H-Y, Chiou A, Tseng KY, Lin H-Y, Chang GL, Chen S-J. Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing. Biosens Bioelectron 2006; 21: 1631-7. http://dx.doi.org/10.1016/j.bios.2005.11.001
Lee W-B, Chen Y-H, Lin H-I, Shiesh S-C, Lee G-B. An integrated microfluidic system for fast, automatic detection of C-reactive protein. Sens Actuators B 2011; 157: 710-21. http://dx.doi.org/10.1016/j.snb.2011.04.087
Deegan O, Walshe K, Kavanagh K, Doyle S. Quantitative detection of C-reactive protein using phosphocholine-labelled enzyme or microspheres. Anal Biochem 2003; 312: 175-81. http://dx.doi.org/10.1016/S0003-2697(02)00439-6
Ablij HC, Meinders AE. C-reactive protein: history and revival. Eur J Intern Med 2002; 13: 412-22. http://dx.doi.org/10.1016/S0953-6205(02)00132-2
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2013 Sandeep Kumar Vashist